These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1335467)

  • 21. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Palestine AG; Polis MA; De Smet MD; Baird BF; Falloon J; Kovacs JA; Davey RT; Zurlo JJ; Zunich KM; Davis M
    Ann Intern Med; 1991 Nov; 115(9):665-73. PubMed ID: 1656826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
    J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Foscarnet and genital lesions].
    Miguélez M; Linares Feria M; Laynez P; Méndez M
    Med Clin (Barc); 1993 May; 100(18):717-8. PubMed ID: 8388069
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis.
    Reddy MM; Grieco MH; McKinley GF; Causey DM; van der Horst CM; Parenti DM; Hooton TM; Davis RB; Jacobson MA
    J Infect Dis; 1992 Sep; 166(3):607-10. PubMed ID: 1323624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
    Ganly PS; Arthur C; Goldman JM; Schulenburg WE
    Postgrad Med J; 1988 May; 64(751):389-91. PubMed ID: 2849092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cytomegalovirus retinitis in patients with AIDS.
    Jabs DA
    Ann Intern Med; 1996 Jul; 125(2):144-5. PubMed ID: 8678370
    [No Abstract]   [Full Text] [Related]  

  • 27. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 28. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
    Chrisp P; Clissold SP
    Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
    Nelson MR; Barter G; Hawkins D; Gazzard BG
    Lancet; 1991 Jul; 338(8761):250. PubMed ID: 1676798
    [No Abstract]   [Full Text] [Related]  

  • 30. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    Polis MA
    Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151.
    Jacobson MA; Kramer F; Bassiakos Y; Hooton T; Polsky B; Geheb H; O'Donnell JJ; Walker JD; Korvick JA; van der Horst C
    J Infect Dis; 1994 Jul; 170(1):189-93. PubMed ID: 8014496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Cunningham ET
    West J Med; 1997 Feb; 166(2):138-9. PubMed ID: 9109331
    [No Abstract]   [Full Text] [Related]  

  • 34. Foscarnet infusion at home.
    Heley A
    Lancet; 1988 Dec; 2(8623):1311. PubMed ID: 2904032
    [No Abstract]   [Full Text] [Related]  

  • 35. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
    Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
    [No Abstract]   [Full Text] [Related]  

  • 36. Foscarnet for CMV retinitis.
    Wood CA
    Lancet; 1992 Feb; 339(8791):501. PubMed ID: 1346861
    [No Abstract]   [Full Text] [Related]  

  • 37. Visual field testing in the management of cytomegalovirus retinitis.
    Bachman DM; Bruni LM; DiGioia RA; Harris PJ; McMackin CM; Pistole MC; Thomas RM; Ward DJ
    Ophthalmology; 1992 Sep; 99(9):1393-9. PubMed ID: 1328981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review.
    Zaknun D; Zangerle R; Kapelari K; Fischer H; Sailer M; McIntosh K
    Pediatr Infect Dis J; 1997 Aug; 16(8):807-11. PubMed ID: 9271045
    [No Abstract]   [Full Text] [Related]  

  • 39. Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
    Jacobson MA
    Am J Med; 1992 Feb; 92(2A):26S-29S. PubMed ID: 1310573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and experimental therapeutic options for cytomegalovirus disease.
    Flaherty JF
    Am J Health Syst Pharm; 1996 Apr; 53(8 Suppl 2):S4-11. PubMed ID: 8728375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.